Replies to post #3 on Furiex Pharmaceuticals Inc (FURX)

[surf1944]

1:30PM Furiex Pharmaceuticals confirms Takeda (TKPYY) launches LIOVEL LD and LIOVEL HD, a fixed dose combination of NESINA and ACTOS, for Type 2 Diabetes in Japan (FURX) 15.99 +0.51 : Under Furiex's agreement with Takeda, this launch does not trigger a milestone payment to Furiex. However, Furiex is entitled to receive royalty payments on sales of LIOVEL.